Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer
Authors:
Abstract
BACKGROUND: Cystectomy is the standard treatment for patients with infiltrating bladder cancer, but conservative treatment with cystoscopic resection followed by radiochemotherapy may be an alternative for highly selected patients. The addition of gemcitabine to cisplatin and radiotherapy may enhance disease control.METHODS: The long‐term clinical outcomes of 26 patients enrolled in a previously published dose‐finding study and a prematurely discontinued phase 2 trial were evaluated. All the patients underwent transurethral tumor resection followed by a radical dose of external radiotherapy administered at the same time as cisplatin and weekly gemcitabine therapy.RESULTS: After a median follow‐up of 74 months, the projected 5‐year clinical outcomes were a 70.1% overall survival rate, a 78.9% disease‐specific survival rate, and a 73.8% bladder‐intact survival rate.CONCLUSIONS: The long‐term follow‐up data from the current study confirmed that the addition of gemcitabine to radiotherapy and cisplatin is safe and leads to good local and distant disease control. The concomitant administration of cisplatin may explain the good long‐term organ preservation that was observed. Conducting confirmatory and comparative trials could satisfy an unmet need but requires the multidisciplinary cooperation of urologists in selecting the right patients for a bladder‐sparing strategy. Cancer 2011. © 2010 American Cancer Society.Keywords
This publication has 16 references indexed in Scilit:
- Combined-Modality Therapy With Gemcitabine and Radiation Therapy as a Bladder Preservation Strategy: Long-Term Results of a Phase I TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder CancerEuropean Urology, 2009
- Cystectomy for Transitional Cell Carcinoma of the Bladder: Results of a Surgery Only Series in the Neobladder EraJournal of Urology, 2006
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient DataEuropean Urology, 2005
- Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesLung Cancer, 2005
- Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I TrialJournal of Clinical Oncology, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958